SNM Annual Meeting Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     



J Nucl Med. 2008; 49 (Supplement 1):289P
This Article
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by von Guggenberg, E.
Right arrow Articles by Decristoforo, C.
PubMed
Right arrow Articles by von Guggenberg, E.
Right arrow Articles by Decristoforo, C.

Radiopharmaceutical Chemistry: New Chemistry-Oncology

New Chemistry-Oncology Posters

Evaluation in vivo and ex vivo of a new stabilized 99mTc-labeled minigastrin derivative

Elisabeth von Guggenberg1, Anna Helbok1, Stephen Mather2, Andreas Artl3 and Clemens Decristoforo1

1 Clinical Department of Nuclear Medicine, Innsbruck Medical University, Innsbruck, Austria; 2 Department of Nuclear Medicine, St. Bartholomew’s Hospital, London, United Kingdom; 3 piCHEM Research & Development, Graz, Austria

1235

Objectives: The development of radiolabeled Minigastrin (MG) derivatives for imaging and therapy of CCK2-receptor expressing tumors such as MTC and SCLC has been hampered by low stability of the native peptide. In this study we describe the evaluation of a new 99mTc-labeled analog stabilized by cyclisation, comparing the organ and tumor uptake in vivo using micro-SPECT/CT imaging with quantification ex vivo.

Methods: Cyclisation of MG was achieved by replacing Gly by DLys at Pos 9 allowing cyclisation with DGlu in Pos 1. 99mTc-labelling was carried out by derivatisation with HYNIC at the N-terminal and with EDDA as coligand. Stability and receptor mediated internalization in CCK2-receptor expressing AR4-2J cells were evaluated. Biodistribution was studied in AR4-2J tumor bearing nude mice, including NanoSPECT/CT imaging. Metabolites in urine, liver and kidneys were analyzed by HPLC.

Results: Cyclo-MG showed improved radiochemical purity in the labelling process, allowing 99mTc-labelling at high specific activities with high yields. The radioligand revealed high stability in vitro and receptor mediated uptake in AR4-2J cells. In the animal tumor model fast renal clearance and low unspecific uptake in most organs were observed. Tumor uptake 1 h p.i. was 3.26 %ID/g in vivo and 3.61 %ID/g ex vivo. The metabolite analysis indicated rapid conversion into the linear peptide sequence and enzymatic degradation in vivo.

Conclusions: Cyclisation of MG only had a limited effect on the stability of radiolabeled MG. Overall biodistribution was comparable to linear analogs. Quantification of the organ and tumor uptake by SPECT/CT image fusion was in accordance with ex vivo data.





This Article
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by von Guggenberg, E.
Right arrow Articles by Decristoforo, C.
PubMed
Right arrow Articles by von Guggenberg, E.
Right arrow Articles by Decristoforo, C.